Competitive DNA transfection formulation via electroporation for human adipose stem cells and mesenchymal stem cells

Michael Flanagan, Jeffrey M. Gimble, Gang Yu, Xueqing Xia, Bruce A. Bunnell, Shulin Li

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Background: Adipose stem cells have a strong potential for use in cell-based therapy, but the current nucleofection technique, which relies on unknown buffers, prevents their use. Results: We developed an optimal nucleofection formulation for human adipose stem cells by using a three-step method that we had developed previously. This method was designed to determine the optimal formulation for nucleofection that was capable of meeting or surpassing the established commercial buffer (Amaxa), in particular for murine adipose stem cells. By using this same buffer, we determined that the same formulation yields optimal transfection efficiency in human mesenchymal stem cells. Conclusions: Our findings suggest that transfection efficiency in human stem cells can be boosted with proper formulation.

Original languageEnglish
Article number7
JournalBiological Procedures Online
Volume14
Issue number1
DOIs
StatePublished - 2012

Keywords

  • Cell therapy
  • Electroporation
  • Formulation
  • Stem cells
  • Transfection

Fingerprint Dive into the research topics of 'Competitive DNA transfection formulation via electroporation for human adipose stem cells and mesenchymal stem cells'. Together they form a unique fingerprint.

Cite this